Invention Grant
US07696216B2 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
失效
芳基 - 喹唑啉/芳基-2-氨基 - 苯基甲酮衍生物
- Patent Title: Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
- Patent Title (中): 芳基 - 喹唑啉/芳基-2-氨基 - 苯基甲酮衍生物
-
Application No.: US10540359Application Date: 2003-12-22
-
Publication No.: US07696216B2Publication Date: 2010-04-13
- Inventor: Eva Altmann , Rene Beerli , Marc Gerspacher , Johanne Renaud , Sven Weiler , Leo Widler
- Applicant: Eva Altmann , Rene Beerli , Marc Gerspacher , Johanne Renaud , Sven Weiler , Leo Widler
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent John Alexander
- Priority: GB0230015.0 20021223
- International Application: PCT/EP03/14741 WO 20031222
- International Announcement: WO2004/056365 WO 20040708
- Main IPC: A61K31/517
- IPC: A61K31/517 ; C07D239/78 ; C07D239/80 ; C07D239/82 ; C07D401/04

Abstract:
A compound of formula (I): wherein R1, R2, R3 and Y are as defined herein, or a pharmaceutically-acceptable and -cleavable ester, or acid addition salt thereof, useful for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable.
Public/Granted literature
- US20060079685A1 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives Public/Granted day:2006-04-13
Information query
IPC分类: